Pharmacy Continence Care - Bladder and Bowel Website

More documents

Recommendations

Info

AUTHORS OF THE REPORT This report has been written by NOVA Public Policy project team members: Rosemary Calder Melbourne 03 9587 3101 rosemary.calder@novapolicy.com Lorraine Wheeler Canberra 02 6231 6814 lorraine.wheeler@novapolicy.com Karen Bentley Canberra 02 6262 9639 karen.bentley@novapolicy.com Kate Moore Canberra 02 6288 2672 kate.moore @novapolicy.com Mark Minford Sydney 02 9344 9130 mark.minford@novapolicy.com NOVA team members who also contributed to this project and report are: Carolyn McLean Melbourne Angela Kirsner Melbourne Final Report iii NOVA Public Policy Pharmacy Continence Care Project
CONTENTS Glossary of Acronyms ..............................................................................................viii Executive Summary...................................................................................................ix 1 Introduction......................................................................................................... 1 1.1 Background and rationale .......................................................................1 1.2 Stage 2 Pharmacy Continence Care Program ............................................2 2 Methodology ........................................................................................................ 6 3 Implementation of the Pilot Program ............................................................... 12 3.1 Training Materials.................................................................................12 3.1.1 Training delivery .................................................................................. 13 3.1.2 Production of training manual ............................................................... 13 3.2 Stakeholder Consultations.....................................................................13 3.3 Pharmacy participation .........................................................................13 3.3.1 Number of pharmacies recruited ........................................................... 15 3.3.2 Training............................................................................................... 15 3.3.3 Reason for participating........................................................................ 16 3.4 Timeframes .........................................................................................17 3.5 Pharmacy implementation of the Program ..............................................17 3.5.1 Use of the project materials as reported by pharmacies.......................... 18 3.6 Consumer participation .........................................................................19 Outcomes and Effectiveness Evaluation ................................................................. 21 3.7 Introduction.........................................................................................21 3.8 Effectiveness of the training ..................................................................23 3.8.1 Administration of the PIQ and PEQ survey questions .............................. 23 3.8.2 Evaluation of the Training Program Survey ............................................ 28 3.8.3 Collection of feedback from the training providers .................................. 32 3.8.4 Results of the pilot Program from the pharmacy perspective................... 33 3.8.5 Enhancing the community pharmacy role............................................... 33 3.8.6 Cost effectiveness for pharmacies ......................................................... 34 3.8.7 Changes in pharmacy behaviour............................................................ 36 3.8.8 Costs/benefits of training and cross-referral to other health professionals 37 3.9 Outcomes for consumers ......................................................................38 3.9.1 Summary of findings from consumer surveys ......................................... 39 3.9.2 Case studies ........................................................................................ 44 Final Report iv NOVA Public Policy Pharmacy Continence Care Project
Page 1 and 2: NOVA Public Policy A registered bus
Page 3: • Abena-Sanicare, contracted by N
Page 7 and 8: Figure 11: Pharmacy responses to PI
Page 9 and 10: Glossary of Acronyms CATI computer
Page 11 and 12: Program was based on assessment of
Page 13 and 14: o CQI points through the QCPP for c
Page 15 and 16: materials, the Pharmacist Training
Page 17 and 18: • evaluation of the pilot program
Page 19 and 20: 2 METHODOLOGY The methodology for t
Page 21 and 22: Consumer recruitment was part of th
Page 23 and 24: methodology that assessed the pilot
Page 25 and 26: 3 IMPLEMENTATION OF THE PILOT PROGR
Page 27 and 28: ased on either their customer popul
Page 29 and 30: • self-paced using the CD-ROM/web
Page 31 and 32: focus was on embedding the practice
Page 33 and 34: and faxed newsletter, of an extensi
Page 35 and 36: prior to training (PIQ) and the sam
Page 37 and 38: Level of knowledge and level of con
Page 39 and 40: 45% 40% 35% 30% 25% 20% 15% 10% 5%
Page 41 and 42: 80% 70% 60% 50% 40% 30% 20% 10% 0%
Page 43 and 44: Average of responses 100 90 80 70 6
Page 45 and 46: Average rating on a four point scal
Page 47 and 48: maternal health services and the Co
Page 49 and 50: 4.2.7 Changes in pharmacy behaviour
Page 51 and 52: predetermined training calendar: mo
Page 53 and 54: measures impact of incontinence on
Page 55 and 56:
In the follow-up survey, there was
Page 57 and 58:
• Did not find incontinence clini
Page 59 and 60:
Her mother’s dementia, coupled wi
Page 61 and 62:
pharmacy staff report increased con
Page 63 and 64:
period with a national recruitment
Page 65 and 66:
o of a data base of training partic
Page 67 and 68:
health education and working in par
Page 69 and 70:
6 RECOMMENDATION AND IMPLEMENTATION
Page 71 and 72:
7 BIBLIOGRAPHY Adair, G., (1984). T
Page 73:
Rosenstock, I. M. (1974). Historica
show all

Pharmacy Continence Care - Bladder and Bowel Website

Create successful ePaper yourself

Delete template?

Save as template?